作者: Anawin Sanguankeo , Sikarin Upala , Wisit Cheungpasitporn , Patompong Ungprasert , Eric L. Knight
DOI: 10.1371/JOURNAL.PONE.0132970
关键词:
摘要: Background HMG CoA reductase inhibitors (statins) are known to prevent cardiovascular disease and improve lipid profiles. However, the effects of statins on renal outcomes, including decline in estimated glomerular filtration rate (eGFR) proteinuria patients with chronic kidney (CKD), controversial. This meta-analysis evaluated impact outcomes CKD.